CUE

AS OF

Jan 14, 04:59 PM (EDT)

Price

$0.33

Change

-$0.02 (-5.71%)

Capitalization

31.11M

68 days until earnings call

Intraday BUY SELL Signals

OUR PRODUCTS

MOBILE APPS

GENERAL INFO

Help

CUE

Stock ticker: NASDAQ

PRICE

CHANGE

CAPITALIZATION

Cue Biopharma (CUE) Ownership - Who owns Cue Biopharma?

Cue Biopharma Inc is a clinical-stage biopharmaceutical company... Show more

Industry: #Biotechnology

Get AI intraday signals

#MovingAverage #Momentum #MACD #Pattern #RSI #Stochastic #Aroon #Bollinger

Profile

Industry

Biotechnology

Address

40 Guest Street

Phone

+1 617 949-2680

Employees

Web

https://www.cuebiopharma.com

Details

Group

Domestic Stock Funds

Fundamentals

CUE

Capitalization

31.1M

P/E Ratio

N/A

Risk (Beta)

1.14

Dividend Yield

N/A

Total Cash

18.7M

Total Cash/Share

0.20

Total Debt

6.17M

Total Debt/Equity

N/A

Projected Growth (PEG Ratio)

N/A

Revenue/Share (as % of the share price)

0.08%

Revenue

7.1M

ROE

N/A

Book Value

13.2M

P/B Ratio

2.35

Cash Flow

N/A

Earnings

-0.41

Average Daily Volume YTD

N/A

Common Shares Outstanding - Security Level

78K

Current Ratio

1.66

Current Revenue Per Employee

52414.63

Dividends Per Share - Security

N/A

EBITDA

-35.19M

Float

N/A

Float - Current

N/A

Gross Income Margin

N/A

Revenue To Assets

-98.58

Shares Held By Institutions

15M

Shares Outstanding - Current

91.2M

Total Liabilities

18.4M

Total Volume MTD

N/A

Value

Gain YTD

14.800

View a ticker or compare two or three

Compare

CUE

Setup

Daily Signal:

Description

Gain/Loss:

Interact to see
Advertisement

A.I.Advisor

published price charts

These past five trading days, the stock lost 0.00% with an average daily volume of 0 shares traded.The stock tracked a drawdown of 0% for this period. CUE showed earnings on November 13, 2025. You can read more about the earnings report here.

View AI-Driven Trading for CUE

A.I. Advisor

published General Information

General Information

a developer of biopharmaceuticals

Industry Biotechnology